Clinical trial
The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease
NCT00331331 · National Eye Institute (NEI), NIH · Completed
Key facts
| NCT number | NCT00331331 |
|---|---|
| Title | The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease |
| Official title | The Vitreous Proteome and Inflammatory Mediators in Ocular Inflammatory Disease |
| Lead sponsor | National Eye Institute (NEI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Uveitis, Vasculitis, Ocular Inflammatory Disease |
| Enrollment | 147 |
| Start date | Feb 14, 2007 |
| Primary completion | Feb 1, 2019 |
| Completion | Feb 1, 2019 |
| First posted | May 29, 2006 |
| Last update posted | Oct 30, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: